{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-169162","form_type":"8-K","ticker":null,"cik":"0001760173","company_name":"SURGALIGN HOLDINGS, INC.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.429182+00:00","generated_at":"2026-06-13T21:32:11.408175+00:00","sec_items":["2.05","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Surgalign cuts 25 jobs, eliminates CCO role; gives CEO/CFO retention bonuses as part of restructuring","bullets":["Workforce reduction of 25 employees expected to save $3.5M annually; one-time severance charge of $242K in Q2 2023.","Chief Commercial Officer William S. Durall's position eliminated; transitions to consultant for 4 months at $33K/month.","CEO Terry Rich receives $550K retention bonus; CFO Dave Lyle receives $350K, with clawback if terminated before Dec 31, 2023 or restructuring completion.","Rich and Lyle eligible for additional incentive bonuses up to $550K and $350K respectively, tied to restructuring milestones."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-169162","json":"https://secwatch.observer/filing/0001193125-23-169162.json","markdown":"https://secwatch.observer/filing/0001193125-23-169162.md","text":"https://secwatch.observer/filing/0001193125-23-169162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760173/000119312523169162/0001193125-23-169162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760173/000119312523169162/d377677d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T21:32:11.408175+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"50622ba219","claim":"William S. Durall departed as Chief Commercial Officer at SURGALIGN HOLDINGS, INC..","evidence_excerpt":"On June 12, 2023, the Company eliminated the position of Chief Commercial Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760173/000119312523169162/0001193125-23-169162-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"},{"claim_id":"93f5b824bfef099f0a9b962f8e69a42d42e7455e","claim":"SURGALIGN HOLDINGS, INC. announced a restructuring with charges of one-time charge of approximately $242,000 in the second quarter of 2023 related to the reduction in workforce affecting workforce reduction (termination of approximately 25 employees).","evidence_excerpt":"on June 16, 2023, Surgalign Holdings, Inc. (the “Company, authorized a reduction in workforce which will result in the termination of approximately 25 employees, effective June 16, 2023.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760173/000119312523169162/0001193125-23-169162-index.htm","confidence":0.95,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"one-time charge of approximately $242,000 in the second quarter of 2023 related to the reduction in workforce"},{"label":"Affected area","value":"workforce reduction"},{"label":"Headcount","value":"termination of approximately 25 employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}